1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Granzyme B degraded type IV collagen products in serum identify melanoma patients responding to immune checkpoint blockade
(
- Contribution to journal › Article
-
Mark
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
(
- Contribution to journal › Article
- 2017
-
Mark
Acquired immune resistance follows complete tumor regression without loss of target antigens or IFNγ signaling
(
- Contribution to journal › Article
- 2015
-
Mark
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
(
- Contribution to journal › Article